GlaxoSmithKline Financial Market Data
| Last Close 17-Jul-2008 |
$46.97 |
Price/ Sales Ratio |
0.44 |
| 52-Week High |
$54.64 |
Price/ Book Ratio |
1.04 |
| 52-Week Low |
$40.51 |
Price/ Earnings Ratio |
24.67 |
| 60-Month Beta |
0.3 |
Price/ Cash Flow Ratio |
1.62 |
| Market Cap (mil.) |
-- |
Return on Assets |
12.6% |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
24.4% |
| Dividend Rate |
2.17 |
Current Ratio |
1.32 |
| Dividend Yield |
217.0% |
Long-Term Debt/Equity |
1.13 |
| # of Institutional Holders |
602 |
% Owned by Institutions |
13.0% |
| Latest Short Interest Ratio |
4.70 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.7% |
16.8% |
34.6% |
| EPS Growth |
3,050.0% |
8.6% |
0.0% |
| Dividend Growth |
15.0% |
39.6% |
72.3% |
This data is provided as per license from EDGAR Online
